Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kineta (KANT)
OTHER OTC:KANT
Holding KANT?
Track your performance easily
KANT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.26 - $2.83
Previous CloseN/A
Volume280.00
Average Volume (3M)45.51K
Market Cap
$5.64M
Enterprise Value$8.11M
Total Cash (Recent Filing)$15.49M
Total Debt (Recent Filing)$14.59M
Price to Earnings (P/E)―
Beta0.33
Next Earnings
Mar 28, 2025EPS EstimateN/A
Last Dividend Ex-Date
Dec 19, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-1.48
Shares Outstanding12,263,203
10 Day Avg. Volume8,380
30 Day Avg. Volume45,514
Standard Deviation0.31
R-Squared0.09
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.93
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.44
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.49
Enterprise Value/Ebitda-0.51
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Kineta News
PremiumCompany Announcements
Kineta Merges with TuHURA to Enhance Cancer Treatment
PremiumCompany Announcements
Kineta and TuHURA Enter Acquisition Agreement
Ownership Overview
29.11% Insiders
0.46% Mutual Funds
3.35% Other Institutional Investors
67.08% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
KANT FAQ
What was Kineta’s price range in the past 12 months?
Kineta lowest stock price was $0.26 and its highest was $2.83 in the past 12 months.
What is Kineta’s market cap?
Kineta’s market cap is $5.64M.
When is Kineta’s upcoming earnings report date?
Kineta’s upcoming earnings report date is Mar 28, 2025 which is in 54 days.
How were Kineta’s earnings last quarter?
Kineta released its earnings results on Nov 01, 2024. The company reported -$0.132 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.132.
Is Kineta overvalued?
According to Wall Street analysts Kineta’s price is currently Overvalued.
Does Kineta pay dividends?
Kineta pays a Notavailable dividend of $1.429 which represents an annual dividend yield of N/A. See more information on Kineta dividends here
What is Kineta’s EPS estimate?
Kineta’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kineta have?
Kineta has 12,263,203 shares outstanding.
What happened to Kineta’s price movement after its last earnings report?
Kineta reported an EPS of -$0.132 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.97%.
Which hedge fund is a major shareholder of Kineta?
Currently, no hedge funds are holding shares in KANT
---
Company Description
Kineta
Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.
---
Technical Analysis
Immutep
―
Fate Therapeutics
―
Sorrento Therapeutics
―
Adaptimmune Therapeutics
―
Hookipa Pharma
―
---